Introduction
Madhya Pradesh High Court, Jabalpur Bench” The court, which declared, “the most shocking case in medical history,” has ruled against the appeal of a Coldrif cough syrup distributor, Rajpal Kataria, who was to be locked away in his property and canceled his drug license on the spot of the tragic death of 30 children.
A Tragedy That Shook the Nation
The nightmare began quietly in August 2025, when children in Chhindwara and Betul districts started falling gravely ill. What began as common cold symptoms gradually became a medical crisis that would cost young lives and testify to catastrophic failures in the Indian pharmaceutical system. Coldrif cough syrup had a fatality rate of at least 30 children under five at the time of October.
Laboratory investigations revealed a chilling discovery: one sample of the syrup contained 48.6 percent diethylene glycol—a highly toxic industrial solvent strictly prohibited in pharmaceutical products. The permissible limit is virtually zero. This poison, disguised as medicine, had been prescribed to sick children by doctors who trusted the system.
The Court’s Stern Rebuke
A Division Bench made up of Chief Justice Sanjeev Sachdeva and Justice Vinay Saraf did not use any punches in its assessment. The court noted that the case of that subject is one of the most shocking medical case in the last 100 years, and the case was unprecedented: hundreds of innocent children were killed in contaminated medications.
Kataria, whose premises were raided on October 2, was found to be distributing the deadly syrup. sealed off his shop and issued show-cause notices on October 9 and 11 as he demanded explanations for possible violations under the Drugs and Cosmetics Rules, 1945.
The distributor had already sent his writ petition to the High Court in what the one judge dismissed his case. His counsel also brought procedural questions, noting that documents needed to argue for his defense were sealed away in the room, and his lawyer requested a more time to respond—a demand cited on October 10.
It was no doubt that the bench of appellate judges remained defiant. It noted that Kataria had an alternative option, but she applied for an appeal before the State Government under the Drug Rules, 1945. In essence the High Court recommended that he be exempt from statutory remedies while seeking justice at the High Court.
A Web of Accountability
This is more than a distributor. The toxic syrup manufactured by Sresan Pharma in Tamil Nadu, owned by Ranganathan Govindan, has been remanded in custody. He was arrested and questioned on bail and then tried to approach the High Court, where Dr. Praveen Soni, a Chhindwara pediatrician who prescribed Coldrif to most of the children, lost his bail application and ultimately applied for bail in court.
In response to the crisis, the Madhya Pradesh government suspended two drug inspectors and a deputy director of the Food and Drug Administration, and transferred the state’s drug controller. The manufacturing unit has been permanently sealed. Even the Supreme Court weighed in when it dismissed a PIL seeking a CBI probe, expressing confidence that state governments would handle the investigation.
What This Means Going Forward
The High Court ruling makes clear how procedural consistency is needed in pharmaceutical regulations cases. While Kataria may appeal through the statutory channels, the court’s characterization of the case as “most shocking” in medical history underscores how the court views the case as “most shocking”.
This tragedy has broken the trust that parents in India owe in a system they could trust to protect their children. The presence of a deadly industrial chemical in medicine intended for infants not simply means negligence but a systemic breakdown that needs to be thoroughly overhauled.
As investigations continue, and more defendants are found to be found to trial, this case will likely become a pivotal moment in Indian drug regulator history, a grim reminder that when safety measures fail, the tiny and most vulnerable get the fate of the biggest and most costly problems.
ABOUT AUTHOR:
Swapnil Mishra is a student at The Legal School and a law graduate of LNCT University in Bhopal. studies corporate and commercial law with a strong interest. Through his writing, he hopes to simplify, make practical, and make difficult legal concepts understandable. has experience in paralegal work, contract preparation, and legal research.